Bruce Car
Equibles does not estimate personal net worth.
Get an email with a short summary when Biohaven Ltd. publishes a filing, an earnings call transcript or a press release.
Get BHVN alertsAbout Bruce Car
Agios Pharmaceuticals, Inc. reported in an 8-K filed May 18, 2022 that Bruce Car resigned as chief scientific officer, effective July 31, 2022. The proxy statement of Biohaven Ltd. reports total compensation of $3,935,078 for Bruce Car in fiscal 2024, including a base salary of $515,567. Disclosed compensation is on record for 7 fiscal years. Biohaven Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Biohaven Ltd. includes Vlad Coric (CEO and Board Member), Matthew Buten (CFO), Warren Volles (General Counsel) and 7 others.
“On May 15, 2022, Bruce Car, Ph.D. notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign as chief scientific officer of the Company, effective July 31, 2022.”
Affiliation history
-
Biohaven Ltd. (BHVN)
Proxy statement
CurrentStart not stated–present
Last confirmed March 13, 2026
-
Agios Pharmaceuticals, Inc. (AGIO)
Proxy statement
Start not stated–2022-07-31
Company network
Leadership on record at Biohaven Ltd.
- Vlad Coric CEO, Board Member
- Matthew Buten CFO
- Warren Volles General Counsel
- Gregory Bailey Board Member
- Irina Antonijevic Board Member
- John Childs Board Member
- John Yetimoglu Board Member
- Julia Gregory Board Member
- Kishan Mehta Board Member
- Michael T. Heffernan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Biohaven Ltd. (BHVN) | Chief Scientific Officer | $515,567 | $3,935,078 |
| 2023 | Biohaven Ltd. (BHVN) | Chief Scientific Officer | $489,850 | $2,584,248 |
| 2022 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Scientific Officer | $309,429 | $1,852,384 |
| 2022 | Biohaven Ltd. (BHVN) | Chief Scientific Officer | $121,250 | $1,773,908 |
| 2021 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Scientific Officer | $515,000 | $2,803,973 |
| 2020 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Scientific Officer | $494,318 | $3,228,043 |
| 2019 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Scientific Officer | — | — |
| 2018 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Scientific Officer | — | — |